Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates

European Journal of Pharmacology

Volumn 390, Issue 1-2, 2000, Pages 67-73

  Alper, Richard H ^a   Nelson, David L ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT(1A) receptor; 35S GTP S binding assay; Cortex; EEDQ; Hippocampus; Receptor reserve; Spare receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; ALKYLATING AGENT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RECEPTOR RESERVE; SEROTONIN; SEROTONIN 1A RECEPTOR; SULFUR 35;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN MEMBRANE; BRAIN REGION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR DENSITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CEREBRAL CORTEX; HIPPOCAMPUS; MALE; PIPERAZINES; PYRIDINES; QUINOLINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0034712019     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00032-7     Document Type: Article

References (32)

1. 1B receptor expression system. Mol. Pharmacol. 43:1993;427-433.
2. 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Eur. J. Pharmacol. 116:1985;175-178.
3. 35S]GTPγS binding in rat hippocampal membranes. Eur. J. Pharmacol. 343:1998;303-312.
4. 7) positively linked to adenylate cyclase. J. Biol. Chem. 268:1993;23422-23426.
5. 1A autoreceptor-mediated inhibition of neurotransmitter synthesis: relationship to receptor reserve. Neuropharmacology. 31:1992;451-459.
6. 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Proc. West. Pharmacol. Soc. 34:1991;387-393.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
8. 1A agonists. Synapse. 14:1993;297-304.
9. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238:1986;248-253.
10. 1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Mol. Pharmacol. 33:1988;178-186.
11. Emerit M.B., Gozlan H., Hall M.D., Hamon M., Marquet A. Irreversible blockade of central 5-HT binding sites by 8-methoxy-2′-chloro-PAT. Biochem. Pharmacol. 34:1985;883-892.
12. 1A receptor antagonist. Behav. Brain Res. 73:1996;337-353.
13. Furchgott R.F., Bursztyn P. Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann. NY Acad. Sci. 144:1967;882-888.
14. Gozlan H., Laporte A.-M., Thibault S., Schechter L.E., Bolaños-Jiménez F., Hamon M. Differential effects of n-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology. 33:1994;423-431.
15. Henry J.M., Roth G.S. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) blockade. Life Sci. 35:1984;899-904.
16. Hoyer D., Boddeke H.W.G.M. Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol. Sci. 14:1993;270-275.
17. 1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Brain Res. 728:1996;130-134.
18. 1A receptor turnover following irreversible blockade with EEDQ. NeuroReport. 7:1996;2717-2721.
19. 1A receptor-mediated regulation of plasma neuroendocrine hormones. J. Pharmacol. Exp. Ther. 271:1994;1246-1252.
20. 1A receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance. Pharmacol. Biochem. Behav. 43:1992;405-411.
21. 1A agonists. Mol. Pharmacol. 37:1990;231-237.
22. A receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: effects of aging. J. Neurochem. 56:1991;1241-1247.
23. Nelson D.L., Herbet A., Bourgoin S., Glowinski J., Hamon M. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol. Pharmacol. 14:1978;983-995.
24. 3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus. Neurochem. Res. 21:1996;167-176.
25. Norman A.B., Eubanks J.H., Creese I. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain. J. Pharmacol. Exp. Ther. 248:1989;1116-1122.
26. 3H]forskolin binding in rat striatum. Life Sci. 44:1989;831-836.
27. 1A receptor mRNA after irreversible inactivation with EEDQ. Mol. Brain Res. 38:1996;233-242.
28. Ruffolo R.R. Important concepts of receptor theory. J. Auton. Pharmacol. 2:1982;277-295.
29. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 95:1988;975-985.
30. 1A binding site. J. Pharmacol. Exp. Ther. 236:1986;118-125.
31. Weiland T., Jakobs K.H. Measurement of receptor-stimulated guanosine 5′-O-(γ-thio)triphosphate binding by G proteins. Meth. Enzymol. 237:1994;3-13.
32. 1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Mol. Pharmacol. 41:1992;1066-1072.